摘要
成人急性感染性腹泻与儿童感染性腹泻在发病率、严重程度、预后等方面有所不同,其治疗以补液、止泻为主,必要时使用抗微生物药物。近年来,成人急性感染性腹泻在补液治疗和益生菌、新止泻药物应用等方面更新了一些新的循证医学证据,在进一步确保现有药物安全性的同时促进了腹泻治疗思路与手段的发展。
Acute infectious diarrhea in adults is different from children infectious diarrhea in incidence rate, severity and prognosis. Fluid infusion and antidiarrheal treatment are suggested first and antibiotics are prescribed under the needed conditions. Current medical evidences in fluid infusion, probiotics and new antidiarrheal medicines for acute infectious diarrhea in adults are summarized in this paper. Accumulated evidences demonstrate that these treatments are safe and effective.
出处
《微生物与感染》
2013年第4期255-260,共6页
Journal of Microbes and Infections
基金
"十二五"国家科技重大专项(2013ZX10003008)
关键词
成人
急性感染性腹泻
益生菌
循证医学
Adult
Acute infectious diarrhea
Probiotic
Evidence-based medicine